Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Symptomatic Sickle Cell Disease
NCT02615847Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Aug 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in sickle cell disease (SCD), sponsored by University of Zurich. Started Aug 2015; status: completed.
02
Drugs
memantine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02615847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615847.